Livial: a review of clinical studies.
Moore
R A
RA
Pain Research and Nuffield Department of Anaesthetics, University of Oxford, The Churchill, UK. andrew.moore@pru.ox.ac.uk
D000342:Affective Symptoms / Q000209:etiology / Q000517:prevention & control; D045930:Anabolic Agents / Q000627:therapeutic use*; D001847:Bone Diseases / Q000209:etiology / Q000517:prevention & control; D001943:Breast Neoplasms / Q000139:chemically induced; D002979:Climacteric / Q000187:drug effects; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D004715:Endometriosis / Q000209:etiology / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000379:methods; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects; D009652:Norpregnenes / Q000627:therapeutic use*; D017698:Postmenopause / Q000187:drug effects*; D016032:Randomized Controlled Trials as Topic; D014592:Uterine Hemorrhage / Q000209:etiology / Q000517:prevention & control; D014623:Vaginal Diseases / Q000209:etiology / Q000517:prevention & control
D045930:Anabolic Agents; D009652:Norpregnenes; C027385:tibolone